Epibiotech Co., Ltd. (XKON:446440)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,000
+1,010 (6.74%)
At close: Dec 5, 2025
6.74%
Market Cap 36.91B
Revenue (ttm) 449.62M
Net Income (ttm) -5.06B
Shares Out 2.31M
EPS (ttm) -2,966.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 260
Average Volume 343
Open 14,000
Previous Close 14,990
Day's Range 14,000 - 16,990
52-Week Range 9,600 - 19,000
Beta 1.26
RSI 52.73
Earnings Date n/a

About Epibiotech

Epibiotech Co., Ltd., a biopharmaceutical research company, develops cell and antibody treatments for hair restoration medical needs. The company was formerly known as Stemore Co., Ltd. and changed its name to Epibiotech Co., Ltd. in May 2021. The company was founded in 2015 and is headquartered in Incheon, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2015
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 446440
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.